Search by Drug Name or NDC
NDC 00832-0542-10 Bumetanide 2 mg/1 Details
Bumetanide 2 mg/1
Bumetanide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Upsher-Smith Laboratories, LLC. The primary component is BUMETANIDE.
MedlinePlus Drug Summary
Bumetanide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease. Bumetanide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.
Related Packages: 00832-0542-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Bumetanide
Product Information
| NDC | 00832-0542 |
|---|---|
| Product ID | 0832-0542_0c33dc02-8c80-408e-867c-cf49549f4a68 |
| Associated GPIs | 37200010000315 |
| GCN Sequence Number | 008223 |
| GCN Sequence Number Description | bumetanide TABLET 2 MG ORAL |
| HIC3 | R1M |
| HIC3 Description | LOOP DIURETICS |
| GCN | 35022 |
| HICL Sequence Number | 003664 |
| HICL Sequence Number Description | BUMETANIDE |
| Brand/Generic | Generic |
| Proprietary Name | Bumetanide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | BUMETANIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUMETANIDE |
| Labeler Name | Upsher-Smith Laboratories, LLC |
| Pharmaceutical Class | Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209916 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00832-0542-10 (00832054210)
| NDC Package Code | 0832-0542-10 |
|---|---|
| Billing NDC | 00832054210 |
| Package | 1000 TABLET in 1 BOTTLE (0832-0542-10) |
| Marketing Start Date | 2018-01-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |